Table 2

Summary of risk factors and outcomes by risk/association category*

Outcome↑Increased risk or positive association—No association↓Decreased risk or
negative association
Hypertensive disorders of pregnancy (eight studies)
Pregnancy-induced hypertensionRural maternal residency1178
Maternal age 35 years or older and smoked during pregnancy1371
Continuous smokeless tobacco use2230
Continuous cigarette smoking2230
Maternal age<35 years and smoked during pregnancy1371
PreeclampsiaNative American maternal race8141
Overweight/obese BMI7372, 835, 836, 837
Age at delivery835,836
Nulliparity835, 836, 837
Gestational diabetes837
Genetic factors (SNPs)
CRP_A, rs3093077, (T allele additive)836
MBL2, rs1800451, (T allele dominant) 836
IL1A, rs3273550, (T allele dominant) 836
CTLA4, rs21775, (A allele dominant) 836
CRP, rs3093068, (G allele additive)837
CRP, rs3093068, (G allele dominant)837
CRP, rs876538, (C allele additive)837
CRP, rs876538, (C allele recessive)837
NOS3, rs1799983, (G allele recessive)835
DDAH1, rs10158674, (C allele recessive)835
DDAH1, rs233115, (A allele recessive)835
Continuous smokeless tobacco use2230
Continuous cigarette smoking2230
Age at delivery 837
BMI8141
Genetic factors (SNPs)
GNB3, rs5442, (A allele dominant)835
Genetic factors (SNPs)
CRP_B, rs1205, (A allele dom)836
CRP_C, rs1130864, (T allele dom)836
CRP, rs876538, (C allele dominant)837
NOS3, rs3918227, (A allele dominant)835
Severe preeclampsiaNulliparity836, 837
Obese BMI836,837
Age at delivery836
Gestational diabetes837
Genetic factors (SNPs)
MBL2, rs1800451, (T allele dominant) 836
IL1A, rs3273550, (T allele dominant)836
CTLA4, rs21775, (A allele dominant)836
CRP, rs3093068, (G allele additive)837
CRP, rs3093068, (G allele dominant)837
CRP, rs876538, (C allele additive)837
CRP, rs876538, (C allele recessive)837
Age at delivery837Genetic factors (SNPs)
CRP_A, rs3093077, (T allele additive)836
CRP_B, rs1205, (A allele dom)836
CRP_C, rs1130864, (T allele dom)836
CRP, rs876538, (C allele dominant)837
SMM and/or mortality (four studies)
SMM with transfusionsNative American maternal race119
Any physical health condition119
Any behavioural health condition119
Multiple chronic conditions (two or more)119
Native American maternal race952
SMM without transfusionsNative American maternal race119
Rural maternal residency4010
SMMMRural maternal residency3421
Native American race4010
Medicaid-funded births3421
Urban maternal residency3421
Blood transfusions (two studies)
Blood transfusionsRural maternal residency3421, 4010
Medicaid-funded births3421
Native American maternal race4010
Postpartum haemorrhage (two studies)
Postpartum haemorrhageNative American maternal race1331
Gravidity<51131
Birth weight>4500 g1131
Retained placenta1131
Magnesium sulfate use1131, 2944
Antepartum bleeding2944
Previous postpartum haemorrhage2944
Third stage of labour≥20 m2944
Maternal rural residence2944
Fetal macrosomia2944
Oxytocin use>12 h2944
Routine aspirin use2944
Prior uterine incision and vaginal delivery2944
Preeclampsia without severe features without use of magnesium sulfate2944
Parity≥52944
Length of second stage of labour≥1 h2944
Inpatient induction length≥ to 36 h2944h2944
Prior uterine incision2944
BMI≥402944
Vitamin D supplementation2944
Other outcomes (four studies)
Uterine atonyNative American maternal race1331
Birth weight>4500 g1331
Gravidity<51331
Induction augmentation1331
Chorioamnionitis1331
Ectopic pregnancyMaternal age≥19 years1861
Indian Health Service region1861
Placental abruptionContinuous use of smokeless tobacco2230
Continuous cigarette smoking2230
DICNative American race4010Rural maternal residency4010
HysterectomyNative American race4010
Rural maternal residency4010
  • Significant associations are italicised and bolded, and significant association in the same direction as categorised.

  • BMI, body mass index; DIC, disseminated intravascular coagulation; h, hours; m, minutes; SMM, severe maternal morbidity; SMMM, severe maternal morbidity and mortality; SNPs, single-nucleotide polymorphisms.